Skip to main content
. 2023 Nov 6;14:1241145. doi: 10.3389/fendo.2023.1241145

Table 3.

Analysis of factors related to postoperative tumor recurrence.

Recurrence Non-Recurrence P Value
Surgical Approach Craniotomy 14 (22.6%) 48 (77.4%) p=0.07
Endoscopic endonasal transsphenoidal 4 (57.1%) 3 (42.9%)
Primary or Recurrence Tumor Primary 16 (25.0%) 48 (75.0%) p=0.60
Recurrence 2 (40.0%) 3 (60.0%)
rhGH Therapy Yes 4 (18.2%) 18 (81.8%) p=0.31
No 14 (29.8%) 33 (70.2%)

rhGH, recombinant human growth hormone.